Garlemald is definitely next, so if somewhere else is going to share the spotlight with it ala Stormblood, I agree I'd rather it be Sharlayan. I'm super interested in Meracydia and don't want it getting the Ala Mhigo treatment (though I also would think/hope Square has learned not to divide the spotlight so unevenly after StB).